Misplaced Pages

Bladder tumor antigen

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.

This is an old revision of this page, as edited by Graham Beards (talk | contribs) at 18:25, 28 December 2024 (creating stub). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Revision as of 18:25, 28 December 2024 by Graham Beards (talk | contribs) (creating stub)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)

The bladder tumour antigen (BTA) test is used in the detection of bladder cancer. It works by detecting raised levels of complement factor H‐related protein (CFHrp), which is produced by cancer cells, in urine. The test can be qualitative, in which just the presence of the antigen is detected or quantitative, in which the amount of the antigen is measured.

References

  1. Soputro NA, Gracias DN, Dias BH, Nzenza T, O'Connell H, Sethi K (September 2022). "Utility of urinary biomarkers in primary haematuria: Systematic review and meta-analysis". BJUI Compass. 3 (5): 334–343. doi:10.1002/bco2.147. PMC 9349596. PMID 35950042.